Monday, March 15th.
My Mondays of running back and forth to Aix are over. My colleague who teaches the same students in the afternoon has broken his arm and cannot return on site to teach for the rest of the semester. I'm sorry he's broken his arm. However, it was nice to be able to have a proper lunch today and to have time for grading papers that would otherwise have been occupied with driving.
As I was beginning my final class of the day, I heard Maëva come in upstairs and report to Sylvain she'd gotten 20/20 on her Warhol presentation. I'm delighted for her. The 19.5/20 she and Neelane received on their India presentation had been eating at her.
For story time, we read A Spree in Paree and finished "The Red-Headed League."
In Covid news, the UK variant currently accounts for 70% of positive test results. They are saying it generates a higher percentage of serious cases and is putting quite a strain on hospitals. An increasing number of European countries are halting use of the Oxford-Astra Zeneca one-dose vaccine due to an alarming number of blood clots in vaccinated individuals, though causality has not yet been proven. France's health minister has declared that benefits currently outweigh the risks so France will continue using the vaccine for the time being. The WHO apparently recommends the same. On a more positive note, perhaps, a fourth vaccine has been approved for use in the EU: Janssen, I think. Studies place its effectiveness at 67%, if I remember correctly. Somewhere in the high sixties, anyway.
4 comments:
It seems that Janssen is the Johnson & Johnson vaccine, which was also approved in the U.S. recently. It was developed by Janssen Pharmaceutical Companies of Johnson & Johnson. First time I've heard that name.
Ahhh. Interesting. Thanks!
I don't know what the 67% "efficacy" means, really. They have also reported that in all the trials, the J&J vaccine was 100% effective preventing illness serious enough to require hospitalization and there were no deaths. That sounds like a very effective vaccine.
20/20 is pretty good. so is 19.5/20 Congrats Maëva!
Post a Comment